Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020
Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The method is hypersensitive and can quantify tiny amounts of hormone or drug level with the help of antibodies.
Radioimmunoassay is used owing to its high sensitivity, which can analyze nanomolar and picomolar concentrations of hormones in biological fluids. RIA has become one of the major tools in various clinical laboratories for diagnostic procedures, such as assessing the plasma levels of most of the hormones, identifying the presence of certain abused drugs, evaluating the presence of hepatitis B surface antigen in donated blood, and others. This technique is also used for the early detection of cancer, treatment of peptic ulcers, research with neurotransmitters, detection of infections, and identification of allergens in food and house dust, and so on.
The increasing usage of RIA in pharmaceutical industries, research labs, and contract research organizations (CROs) has led to an increased demand of products that are based on this technique. Furthermore, the rising need for quality and error-free results to ensure patient satisfaction has resulted in research labs and diagnostic centers to opt for high-throughput and automated procedures. This is also one of the major factors that have resulted in the growth of the RIA market to a large extent.
The global radioimmunoassay market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million in 2020 at a CAGR of 3.5% from 2015-2020.
There are two types of radioimmunoassay, which serve different functions for clinical diagnostics and research purposes. These types have been classified into reagents & kits and analyzers. In 2014, the reagents & kits segment contributed the largest share of 82.9% to the global radioimmunoassay market.
The various application areas of RIA are infectious disease testing, endocrine testing, allergy testing, oncology testing, toxicology testing, and autoimmune disease testing. Out of all the application segments, oncology testing is the largest application segment, and is expected to hold the major market share in the near future. The major reason behind this is the growth in the oncology market due to various factors, such as the increasing incidence rate of cancer, growth in aging population, urbanization with heavy pollution, and others. The research segment contributed the largest share to the global radioimmunoassay market in 2014. This segment was valued at $227.8 Million in 2014, and is projected to grow at a CAGR of 3.7% during the forecast period from 2015 to 2020.
Based on this market’s end users, the global radioimmunoassay market has been segmented into hospitals (hospital-based laboratories/hospital-attached laboratories), academics, pharmaceutical industry and CROs, clinical laboratories, and others, which include physician offices, patient self-testing centers, blood banks, home health agencies, nursing homes, and ambulatory surgical centers.
The global radioimmunoassay market has been categorized into major geographical regions, including Europe, North America, Asia, and the Rest of the world. Europe is the most dominant region in the global radioimmunoassay market, and contributed a share of 35.1% in 2014; the market in this region was valued at $121.5 Million in the same year.
Some of the major players in the radioimmunoassay globally are DIAsource ImmunoAssays SA (Belgium), Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A.. (Italy), EMD Millipore (U.S.), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), Stratec Biomedical AG (Germany), and others.
Want to explore hidden markets that can drive new revenue in Radioimmunoassay Market?
This report categorizes the global market on the basis of type, application, end user, and region.
Market Segmentation, by Type:
Based on type, the global radioimmunoassay market is segmented into reagents & kits and analyzers.
Market Segmentation, by Application:
Based on application, the global radioimmunoassay market is classified into clinical diagnostics and research.
Market Segmentation, by End User:
Based on end-user, the market is segmented into hospitals, pharmaceuticals industry &CRO, academics, and clinical diagnostic laboratories, and others.
Market Segmentation, by Region:
The regional analysis covers North America, Europe, Asia-Pacific, and RoW.
Customization Options : Radioimmunoassay Market
A company’s specific needs can be met by the customization. Customize to get a comprehensive summary of the industry standards and a detailed analysis of the following parameters: Product Analysis, Brand/Product Perception Matrix, Porters Five Force’s Analysis, Regulatory Frame Work, and Competitive Intelligence.
This report on the global radioimmunoassay market is analysed and segmented on the basis of type, application, end user, and region. It analyzes the competitive developments, such as alliance, joint venture, and merger & acquisition, in the global radioimmunoassay market. This market is also analyzed with an explicit focus on the high-growth applications and fastest-growing market segments.
The technique of radioimmunoassay (RIA) is advanced and sensitive enough to find small molecules in the blood, and is therefore used for research purposes and diagnosis of diseases, such as cancer. This technique is also implemented by organizations and research labs for specific research purposes that use animal or human serum. The new range of immunoassay kits and analyzers provide remedies for autoimmune diseases, such as diabetes. These are widely used in the process of drug discovery and screening in blood banks.
Radioimmunoassay (RIA) is one of the pivotal and traditional methods used for the testing of endocrinological disorders. RIA also has a prominent usage in the field of neurodegenerative disorders. Despite its high precision, robust nature, and impeccable sensitivity, the global radioimmunoassay market has been witnessing a slow growth, in terms of market value and kit volume. This can be attributed to the paradigm shift in the adoption of alternatives, such as ELISA, chemiluminescence assay, immunofluorescence assay, other non-radio techniques, and lack of automation.
Handling of RIA kits and tracers require special license, which in itself constitute to be a complicated process. Stringent regulatory approvals are required to set up laboratories to conduct RIA procedures. Therefore, skilled and expert professionals are required to be hired to perform RIA tests. As a result of this, the global radioimmunoassay market has been witnessing a slow growth rate.
In Europe, many clinical laboratories are adopting measures to remove RIA tests off their shelf; ELISA has been instrumental in taking over the RIA tests. European Greens is significant in the maintenance of environmental responsibility across different regions. The utilization of radioactive substances in RIA procedures poses a threat to environment and human health. Thus, the present scenario has negatively impacted the usage of RIA tests in Europe due to the conscious effort from the European Greens to replace this. Despite the aforementioned dynamics, Europe captures a major market share in the global RIA market. Majority of the RIA manufacturers are based out of Europe, thereby claiming a strong footprint in Europe.
Siemens recently discontinued the production of their RIA kits, which left its customers with the option of seeking replacement products. This event has resulted in an opportunity for other RIA players to achieve growth in the global RIA market. Companies, such as IBL International (A Tecan Company) (U.S.), DIAsource Immunoassays SA (Italy), DRG International, Inc. (U.S.), and MP Biomedicals, LLC (U.S.), can leverage upon this opportunity to enhance their profits.
The global radioimmunoassay market was dominated by Europe in 2014, followed by North America, Asia, and the Rest of the World (RoW). Europe is expected to continue to lead the market in the coming years, followed by North America. Over the years, there has been a significant growth in the utilization of the radioimmunoassay technique in Europe owing to the advancements in medical research, clinical trials, and pharmaceutical industries. Over the next five years, the growth in the Asian Radioimmunoassay (RIA) Market is expected to be centred in China, India, and Japan. The growth in this region is anticipated to be mainly driven by factors, such as the increasing number of tests performed, rising adoption rate of advanced techniques, and rising intrinsic demand from China and India due to their respective large population base. The market in Asia is projected to grow at the highest CAGR of 4.5% during the forecast period from 2015 to 2020.
The global radioimmunoassay market was valued at $345.2 Million in 2014. The European radioimmunoassay (RIA) market contributed the largest share to the global market, and was valued at $121.5 Million in 2014. It is projected to grow at a CAGR of 3.9% during the forecast period from 2015 to 2020. North America was the second-largest market, and the market in this region is expected to be driven by the gradually increasing awareness, investments by government & non-government organizations, and establishment of research centres.
Some of the major players in the radioimmunoassay market are DIAsource ImmunoAssays SA (Belgium), Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A.. (Italy), EMD Millipore (U.S.), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany), and others.
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Table of Contents
1 Introduction (Page No. - 13)
1.1 Objectives of the Study
1.2 Market Segmentation & Coverage
1.3 Stakeholders
2 Research Methodology (Page No. - 15)
2.1 Integrated Ecosystem of the Radioimmunoassay Market
2.2 Arriving at the Radioimmunoassay Market Size
2.2.1 Top-Down Approach
2.2.2 Macro Indicator-Based Approach
2.3 Assumptions
3 Executive Summary (Page No. - 20)
4 Market Overview (Page No. - 22)
4.1 Introduction
4.2 Comparison With Immunoassay Market (Parent Market)
4.3 Market Drivers and Inhibitors
5 Radioimmunoassay (RIA) Market, By Type (Page No. - 27)
5.1 Introduction
5.2 Reagents & Kits Market
5.3 Analyzers Market
6 Radioimmunoassay (RIA) Market, By End User (Page No. - 32)
6.1 Introduction
6.2 Hospital
6.3 Pharmaceutical Industry and CRO
6.4 Academics
6.5 Clinical Diagnostic Laboratories
7 Radioimmunoassay (RIA) Market, By Application (Page No. - 39)
7.1 Introduction
7.2 Research
7.3 Clinical Diagnostics
8 Radioimmunoassay Market, By Geography (Page No. - 48)
8.1 Introduction
8.2 Europe
8.2.1 By Type
8.2.2 By Application
8.2.3 By End User
8.2.4 By Country
8.2.4.1 Germany
8.2.4.2 France
8.2.4.3 U.K.
8.2.4.4 Italy
8.2.4.5 Spain
8.3 North America
8.3.1 By Type
8.3.2 By Application
8.3.3 By End User
8.3.4 By Country
8.3.4.1 U.S.
8.3.4.2 Canada
8.3.4.3 Mexico
8.4 Asia
8.4.1 By Type
8.4.2 By Application
8.4.3 By End User
8.4.4 By Country
8.4.4.1 China
8.4.4.2 Japan
8.4.4.3 India
8.4.4.4 Republic of Korea
8.5 Rest of the World (RoW)
8.5.1 By Type
8.5.2 By Application
8.5.3 By End User
9 Competitive Landscape (Page No. - 82)
9.1 Company Share Analysis
10 Company Profiles (Page No. - 85)
(Business Overview, Products & Services, Key Insights, Recent Developments, MnM View)*
10.1 Diasorin S.P.A.
10.2 Euro Diagnostica AB
10.3 Merck Millipore Corporation
10.4 Diasource Immunossays S.A
10.5 Stratec Biomedicals AG
10.6 Berthold Technologies Gmbh & Co. Kg
10.7 Izotop
10.8 Beckman Coulter, Inc.
10.9 Cisbio
10.10 MP Biomedicals LLC
10.11 Perkinelmer, Inc.
10.12 IBL International (A Tecan Company)
10.13 DRG International, Inc.
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
11 Appendix (Page No. - 112)
11.1 Customization Options
11.1.1 Product Analysis
11.1.2 Brand/Product Perception Matrix
11.1.3 Porter’s Five Forces Analysis
11.2 Related Reports
List of Tables (75 Tables)
Table 1 Immunoassay Market Size & Radioimmunoassay Market Size, 2014 (USD Million)
Table 2 Radioimmunoassay (RIA) Market: Comparison With Immunoassay Market (Parent Market), 2013–2020 (USD Million)
Table 3 Radioimmunoassay (RIA) Market, By Type, 2013-2020 (USD Million)
Table 4 Radioimmunoassay (RIA) Market, By End-User , 2013-2020 (USD Million)
Table 5 Radioimmunoassay (RIA) Market, By Application, 2013-2020 (USD Million)
Table 6 Radioimmunoassay Market, By Geography, 2013-2020 (USD Million)
Table 7 Radioimmunoassay (RIA) Market: Drivers and Inhibitors
Table 8 Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 9 Radioimmunoassay (RIA) Reagents & Kits Market, By Geography, 2013–2020 (USD Million)
Table 10 Radioimmunoassay (RIA) Analyzers Market, By Geography, 2013–2020 (USD Million)
Table 11 Radioimmunoassay (RIA) Market, By End-Users, 2013–2020 (USD Million)
Table 12 Radioimmunoassay (RIA) Market in Hospitals, By Geography, 2013–2020 (USD Million)
Table 13 Radioimmunoassay (RIA) Market in Pharmaceutical Industry and CRO, By Geography, 2013–2020 (USD Million)
Table 14 Radioimmunoassay (RIA) Market in Academics, By Geography, 2013–2020 (USD Million)
Table 15 Radioimmunoassay (RIA) Market in Clinical Diagnostic Laboratories, By Geography, 2013–2020 (USD Million)
Table 16 Radioimmunoassay (RIA) Market, By Application, 2013-2020 (USD Million)
Table 17 Radioimmunoassay (RIA) Market in Research, By Geography, 2013-2020 (USD Million)
Table 18 Radioimmunoassay (RIA) Analyzers Market in Research Application, By Geography, 2013-2020 (USD Million)
Table 19 Radioimmunoassay (RIA) Kits & Reagents Market in Research Application, By Geography, 2013-2020 (USD Million)
Table 20 Radioimmunoassay (RIA) Market in Clinical Diagnostics, By Geography, 2013-2020 (USD Million)
Table 21 Radioimmunoassay (RIA) Analyzers Market in Clinical Diagnostics Application, By Geography, 2013-2020 (USD Million)
Table 22 Radioimmunoassay (RIA) Kits & Reagents Market in Clinical Diagnostics Application, By Geography, 2013-2020 (USD Million)
Table 23 Radioimmunoassay (RIA) Market, By Geography, 2013-2020 (USD Million)
Table 24 Europe: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 25 Europe: Market, By Application, 2013-2020 (USD Million)
Table 26 Europe: Radioimmunoassay (RIA) Analyzers Market, By Application, 2013-2020 (USD Million)
Table 27 Europe: Radioimmunoassay (RIA) Reagents & Kits Market, By Application, 2013-2020 (USD Million)
Table 28 Europe: Market, By End User, 2013-2020 (USD Million)
Table 29 Germany: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 30 Germany: Market, By Application, 2013-2020 (USD Million)
Table 31 France: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 32 France: Market, By Application, 2013-2020 (USD Million)
Table 33 U.K. Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 34 U.K. Market, By Application, 2013-2020 (USD Million)
Table 35 Italy Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 36 Italy Radioimmunoassay (RIA) Market, By Application, 2013-2020 (USD Million)
Table 37 Spain Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 38 Spain Market, By Application, 2013-2020 (USD Million)
Table 39 North America: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 40 North America: Market, By Application, 2013-2020 (USD Million)
Table 41 North America: Radioimmunoassay (RIA) Analyzers Market, By Application, 2013-2020 (USD Million)
Table 42 North America: Radioimmunoassay (RIA) Kits & Reagents Market, By Application, 2013-2020 (USD Million)
Table 43 North-America: Market, By End-User, 2013-2020 (USD Million)
Table 44 U.S.: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 45 U.S.: Market, By Application, 2013-2020 (USD Million)
Table 46 Canada: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 47 Canada: Radioimmunoassay (RIA) Market, By Application, 2013-2020 (USD Million)
Table 48 Mexico: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 49 Mexico: Market, By Application, 2013-2020 (USD Million)
Table 50 Asia: Radioimmunoassay (RIA) Market, By Type, 2013-2020 (USD Million)
Table 51 Asia: Radioimmunoassay Market, By Application, 2013-2020 (USD Million)
Table 52 Asia: Radioimmunoassay (RIA) Analyzers Market, By Application, 2013-2020 (USD Million)
Table 53 Asia: Radioimmunoassay (RIA) Reagents & Kits Market, By Application, 2013-2020 (USD Million)
Table 54 Asia: Radioimmunoassay Market, By End User, 2013-2020 (USD Million)
Table 55 China: Radioimmunoassay (RIA) Market, By Type, 2013-2020 (USD Million)
Table 56 China: Market, By Application, 2013-2020 (USD Million)
Table 57 Japan: Radioimmunoassay (RIA) Market, By Type, 2013-2020 (USD Million)
Table 58 Japan: Market, By Application, 2013-2020 (USD Million)
Table 59 India: Market, By Type, 2013-2020 (USD Million)
Table 60 India: Radioimmunoassay Market, By Application, 2013-2020 (USD Million)
Table 61 Republic of Korea: Radioimmunoassay (RIA) Market, By Type, 2013-2020 (USD Million)
Table 62 Republic of Korea: Market, By Application, 2013-2020 (USD Million)
Table 63 RoW: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 64 RoW: Radioimmunoassay Market, By Application, 2013-2020 (USD Million)
Table 65 RoW: Radioimmunoassay (RIA) Analyzers Market, By Application, 2013-2020 (USD Million)
Table 66 RoW: Radioimmunoassay (RIA) Reagents & Kits Market, By Application, 2013-2020 (USD Million)
Table 67 RoW: Market, By End User, 2013-2020 (USD Million)
Table 68 Radioimmunoassay (RIA) Kits Market: Company Share Analysis, 2014 (%)
Table 69 Radioimmunoassay (RIA) Analyzers Market: Company Share Analysis, 2014 (%)
Table 70 Diasorin S.P.A: Revenue Mix, 2010-2014 (USD Million)
Table 71 Merck Millipore Corporation: Key Financials, 2010-2014 (USD Million)
Table 72 Stratec Biomedical AG: Revenue Mix, 2010-2014 (USD Million)
Table 73 Danaher Corporations: Key Financials, 2011-2014 (USD Million)
Table 74 Perkinelmer, Inc.: Key Financials, 2010-2014 (USD Million)
Table 75 Tecan Trading AG: Key Financials, 2010-2014 (USD Million)
List of Figures (68 Figures)
Figure 1 Market Segmentation & Coverage
Figure 2 Integrated Ecosystem
Figure 3 Top-Down Approach
Figure 4 Macro Indicator-Based Approach
Figure 5 Market Snapshot, 2014 (%)
Figure 6 Comparison With Immunoassay Market (Parent Market), 2013-2020 (USD Million)
Figure 7 Radioimmunoassay (RIA) Type Market, By Type, 2014 & 2020 (USD Million)
Figure 8 Radioimmunoassay (RIA) End User Market, By Geography, 2014 (USD Million)
Figure 9 Radioimmunoassay (RIA) Application Market, By Geography, 2014 (USD Million)
Figure 10 Market, By Type, 2014 & 2020 (USD Million)
Figure 11 Market, Type Comparison With Parent Market, 2013-2020 (USD Million)
Figure 12 Radioimmunoassay (RIA) Reagents & Kits Market, By Geography, 2014 & 2020 (USD Million)
Figure 13 Radioimmunoassay (RIA) Analyzers Market, By Geography, 2014 & 2020 (USD Million)
Figure 14 Market, By End User, 2014 & 2020 (USD Million)
Figure 15 Radioimmunoassay (RIA) Hospitals Market, By Geography, 2014 & 2020 (USD Million)
Figure 16 Radioimmunoassay Market in Pharmaceutical Industry and CRO, By Geography, 2014 & 2020 (USD Million)
Figure 17 Radioimmunoassay Market in Academics, By Geography, 2014 & 2020 (USD Million)
Figure 18 Radioimmunoassay Market in Clinical Diagnostic Laboratories, By Geography, 2014 & 2020 (USD Million)
Figure 19 Radioimmunoassay Market, By Application, 2014 & 2020 (USD Million)
Figure 20 Radioimmunoassay Market in Research, By Geography, 2014 & 2020 (USD Million)
Figure 21 Radioimmunoassay (RIA) Analyzers Market in Research Application, By Geography, 2014 & 2020 (USD Million)
Figure 22 Radioimmunoassay (RIA) Kits & Reagents Market in Research Application, By Geography, 2014 & 2020 (USD Million)
Figure 23 Market in Clinical Diagnostics, By Geography, 2014 & 2020 (USD Million)
Figure 24 Radioimmunoassay (RIA) Analyzers Market in Clinical Diagnostics Application, By Geography, 2014 & 2020 (USD Million)
Figure 25 Radioimmunoassay (RIA) Kits & Reagents Market in Clinical Diagnostics Application, By Geography, 2014 & 2020 (USD Million)
Figure 26 Europe: Radioimmunoassay Market Overview, 2014 & 2020 (%)
Figure 27 Europe: Market, By Type, 2014 & 2020 (USD Million)
Figure 28 Europe: Radioimmunoassay (RIA) Market, By Application, 2014 & 2020 (USD Million)
Figure 29 Europe: Radioimmunoassay Market (RIA), By End User, 2014 & 2020 (USD Million)
Figure 30 Europe: Radioimmunoassay (RIA) Market, By Country, 2014 & 2020 (USD Million)
Figure 31 Germany: Radioimmunoassay (RIA) Market Overview, 2014 & 2020 (%)
Figure 32 France: Radioimmunoassay (RIA) Market Overview, 2014 & 2020 (%)
Figure 33 U.K.: Radioimmunoassay (RIA) Market, Overview, 2014 & 2020 (%)
Figure 34 Italy: Radioimmunoassay (RIA) Market, Overview 2014 & 2020 (%)
Figure 35 Spain: Radioimmunoassay (RIA) Market Overview 2014 & 2020 (%)
Figure 36 North America Radioimmunoassay (RIA) Market Overview, 2014 & 2020 (%)
Figure 37 North America Radioimmunoassay (RIA) Market, By Type, 2014 & 2020 (USD Million)
Figure 38 North America Radioimmunoassay (RIA) Market, By Application, 2014 & 2020 (USD Million)
Figure 39 North America Radioimmunoassay (RIA) Market, By End User, 2014 & 2020 (USD Million)
Figure 40 North America Radioimmunoassay (RIA) Market, By Country, 2014 & 2020, (USD Million)
Figure 41 U.S. Radioimmunoassay (RIA) Market Overview 2014 & 2020 (%)
Figure 42 Canada: RIA Market Overview, 2014 & 2020 (%)
Figure 43 Mexico: RIA Market Overview, 2014 & 2020 (%)
Figure 44 Asia: Radioimmunoassay (RIA) Market Overview, 2014 & 2020 (%)
Figure 45 Asia: RIA Market, By Type, 2014 & 2020 (USD Million)
Figure 46 Asia: Radioimmunoassay Market, By Application, 2014 & 2020 (USD Million)
Figure 47 Asia: Radioimmunoassay Market, By End User, 2014 & 2020 (USD Million)
Figure 48 Asia: Radioimmunoassay Market, By Country, 2014 & 2020 (USD Million)
Figure 49 China: Radioimmunoassay Market Overview, 2014 & 2020 (%)
Figure 50 Japan: Radioimmunoassay Market, Overview 2014 &2020 (%)
Figure 51 India: Radioimmunoassay Market, Overview 2014 & 2020 (%)
Figure 52 Republic of Korea: Radioimmunoassay Market, Overview 2014 & 2020 (%)
Figure 53 RoW: Market Overview, 2014 & 2020 (%)
Figure 54 RoW: Radioimmunoassay Market, By Country, 2014 & 2020 (USD Million)
Figure 55 RoW: Radioimmunoassay Market, By Type, 2014 & 2020 (USD Million)
Figure 56 RoW: Radioimmunoassay Market, By Application, 2014 & 2020 (USD Million)
Figure 57 RoW: Radioimmunoassay Market, By End User, 2014 & 2020 (USD Million)
Figure 58 Radioimmunoassay (RIA) Kits Market: Company Share Analysis, 2014 (%)
Figure 59 Radioimmunoassay (RIA) Analyzers Market: Company Share Analysis, 2014 (%)
Figure 60 Radioimmunoassay Market: Key Players Operating in Application Areas
Figure 61 Coverage of Key Players By Application
Figure 62 Diasorin S.P.A: Revenue Mix 2014(%)
Figure 63 Diasorin S.P.A: Key Financials, 2010-2014 (USD Million)
Figure 64 Merck Millipore Corporation: Key Financials, 2010-2014 (USD Million)
Figure 65 Stratec Biomedical AG: Key Financials, 2010-2014 (USD Million)
Figure 66 Danaher Corporations: Revenue Mix, 2014 (%)
Figure 67 Perkinelmer, Inc.: Revenue Mix, 2014 (%)
Figure 68 Tecan Trading AG: Revenue Mix, 2014 (%)
Generating Response ...
Growth opportunities and latent adjacency in Radioimmunoassay Market